Cargando…
Severity of self-reported symptoms and psychological burden 6-months after hospital admission for COVID-19: a prospective cohort study
OBJECTIVES: Few studies have reported clinical COVID-19 sequelae six months (M6) after hospital discharge, but none has studied symptom severity. METHODS: Prevalence and severity of 7 symptoms were estimated until M6 using the self-administered influenza severity scale in COVID-19 hospitalized patie...
Autores principales: | ELOY, Philippine, TARDIVON, Coralie, MARTIN-BLONDEL, Guillaume, ISNARD, Margaux, TURNIER, Paul LE, MARECHAL, Marion LE, CABIÉ, André, LAUNAY, Odile, TATTEVIN, Pierre, SENNEVILLE, Eric, ANSART, Séverine, GOEHRINGER, François, CHIROUZE, Catherine, BOUSSON, Laurane, LAOUÉNAN, Cédric, ETIENNE, Manuel, NGUYEN, Duc, GHOSN, Jade, DUVAL, Xavier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8432979/ https://www.ncbi.nlm.nih.gov/pubmed/34517049 http://dx.doi.org/10.1016/j.ijid.2021.09.011 |
Ejemplares similares
-
Prevalence of post-acute coronavirus disease 2019 symptoms twelve months after hospitalization in participants retained in follow-up: analyses stratified by gender from a large prospective cohort
por: Ghosn, Jade, et al.
Publicado: (2023) -
Persistent COVID-19 symptoms are highly prevalent 6 months after hospitalization: results from a large prospective cohort
por: Ghosn, Jade, et al.
Publicado: (2021) -
Staphylococcus aureus Bloodstream Infection in Patients With Prosthetic Joints in the Prospective VIRSTA Cohort Study: Frequency and Time of Occurrence of Periprosthetic Joint Infection
por: Dufour, Sébastien, et al.
Publicado: (2019) -
Modeling SARS-CoV-2 viral kinetics and association with mortality in hospitalized patients from the French COVID cohort
por: Néant, Nadège, et al.
Publicado: (2021) -
No increased prevalence of autoantibodies neutralizing type I IFNs in idiopathic pulmonary fibrosis patients
por: Philippot, Quentin, et al.
Publicado: (2023)